Skin Microbiome of Chinese Population Cohort Study

Skin Microbiome Clinical Trial

Official title:

Skin Microbiome of Chinese Population Cohort Study: Association Between Human Health and Skin Microbiome

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05804851
• Other study ID #: 20230103TL001
• Status: Active, not recruiting
• Start date: May 8, 2023
• Est. completion date: July 7, 2025

Study information

• Verified date: February 2023
• Source: Westlake University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes?

Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 237
• Est. completion date: July 7, 2025
• Est. primary completion date: July 7, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 15 Years to 50 Years

Eligibility

Inclusion Criteria:

• ages from 15 to 50.

Exclusion Criteria:

• a severe medical history, including a history of surgery or medication, or serious illnesses such as cancer, liver disease, kidney disease, or craniocerebral trauma.

• recent medical treatment (topical antibiotics, corticosteroids, and other anti-inflammatory drugs within 4 weeks, and systemic antibiotics, corticosteroids, and other immunosuppressive drugs within 6 months)

Related Conditions & MeSH terms

• Skin Microbiome

Locations

Country	Name	City	State
China	Westlake University	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Westlake University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in facial microbiota profiling	Quantitative and qualitative analysis of bacteria population from the sample, rRNA and metagenome sequencing will be conducted on each sample	Day 1, Day 90, Day 180, Day 270, and Day 360